Protagonist Therapeutics Inc (PTGX)
EBITDA
$85.88M
TTM · Period ending: · USD
PTGX EBITDA
Latest reported$85.88Mperiod ending
Latest reported$85.88Mperiod ending
PTGX TTM EBITDA (-$14.55M → $85.88M)
TTM EBITDA
High-resolution chart · PNG
PTGX ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| 85,879,000 | |
| -113,927,000 | |
| -128,031,000 | |
| 49,511,000 | |
| 55,506,000 | |
| 59,985,000 | |
| 282,303,000 | |
| 176,270,000 | |
| 175,975,000 | |
| 168,152,000 | |
| -75,643,000 | |
| -135,506,000 | |
| -132,607,000 | |
| -135,162,000 | |
| -122,366,000 | |
| -127,658,000 | |
| -130,379,000 | |
| -120,399,000 | |
| -123,699,000 | |
| -104,909,000 | |
| -78,955,000 | |
| -66,179,000 | |
| -61,782,000 | |
| -57,869,000 | |
| -66,595,000 | |
| -79,340,000 | |
| -73,671,000 | |
| -74,670,000 | |
| -68,036,000 | |
| -46,922,000 | |
| -41,742,000 | |
| -29,854,000 | |
| -25,488,000 | |
| -31,457,000 | |
| -37,491,000 | |
| -45,417,000 | |
| -47,600,000 | |
| -39,567,000 | |
| -32,349,000 | |
| -25,941,000 | |
| -22,858,000 | |
| -18,883,000 | |
| -14,547,000 |